Transcatheter Aortic Valve Replacement - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Abstract

Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement
Transcatheter Aortic Valve Replacement in Patients With Multivalvular Heart Disease
Transcatheter Aortic Valve Implantation Represents an Anti-Inflammatory Therapy Via Reduction of Shear Stress–Induced, Piezo-1–Mediated Monocyte Activation
Infective endocarditis after transcatheter aortic valve implantation: a nationwide study
A Controlled Trial of Rivaroxaban After Transcatheter Aortic-Valve Replacement
Minimalist transcatheter aortic valve replacement: The new standard for surgeons and cardiologists using transfemoral access?
Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement
Impact of myocardial fibrosis on left ventricular remodelling, recovery, and outcome after transcatheter aortic valve implantation in different haemodynamic subtypes of severe aortic stenosis
Prognostic implications of baseline 6‐min walk test performance in intermediate risk patients undergoing transcatheter aortic valve replacement
Valve‐in‐Valve for Degenerated Transcatheter Aortic Valve Replacement Versus Valve‐in‐Valve for Degenerated Surgical Aortic Bioprostheses: A 3‐Center Comparison of Hemodynamic and 1‐Year Outcome

Original Research

Volume 41, Issue 20, 21 May 2020, Pages 1903–1914

JOURNAL：Eur Heart J.

Impact of myocardial fibrosis on left ventricular remodelling, recovery, and outcome after transcatheter aortic valve implantation in different haemodynamic subtypes of severe aortic stenosis

M Puls, BE Beuthner, R Topci et al.

2690

Keywords: aortic stenosis, myocardial fibrosis, endomyocardial biopsy, TAVR

Full Text PDF